Search
Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a "Dream Team" leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women's cancers.
Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed.
A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.
A large study that analyzed nearly 120,000 cells in a developing mouse embryo is full of surprises.
Take a look back at some of the biggest science stories from this past year.
MSK investigators have used a lab tool originally developed to study fly nerve cells to uncover new findings about acute myeloid leukemia.
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
New research from Sloan Kettering Institute investigators pinpoints altered cell metabolism as a cause of B cell lymphoma.
Research from investigators at the Sloan Kettering Institute shows how a brain circuit controls mating behavior in fruit flies.